ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2021

The survival impact of CKS1B gains or amplification is dependent on the background karyotype and TP53 deletion status in patients with myeloma.

Suyang Hao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.